Back to mobile site
Get it on Google Play

NetraMark wins phase 3 clinical trial contract from global biopharma

December 11, 2025 8:30 AM EST Send to a Friend
NetraMark Holdings Inc. (CSE: AIAI) (OTCQB: AINMF) announced it secured a contract from a global biopharmaceutical company to provide analytics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login